US public health agency recommends prophylactic doxycycline to reduce STIs
BMJ 2023; 383 doi: https://doi.org/10.1136/bmj.p2339 (Published 09 October 2023) Cite this as: BMJ 2023;383:p2339- Janice Hopkins Tanne
- New York
The US public health agency has proposed that the antibiotic doxycycline is used prophylactically in people at risk of contracting chlamydia, gonorrhoea, and syphilis up to three days after possible exposure.1
The US Centers for Disease Control and Prevention (CDC) said that the preventative action was needed in the face of increasing sexually transmitted infections (STIs). The draft recommendation proposes treatment with doxycycline up to three days after potential exposure. CDC said that this was “a new approach to tackling STI prevention in populations at increased risk.” The groups for whom treatment was an option included young people; gay, bisexual, and other men who have sex with men; pregnant women; transgender …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.